[go: up one dir, main page]

WO2009006638A3 - Peptides facilitant le transport rétrograde et utilisations de ceux-ci - Google Patents

Peptides facilitant le transport rétrograde et utilisations de ceux-ci Download PDF

Info

Publication number
WO2009006638A3
WO2009006638A3 PCT/US2008/069365 US2008069365W WO2009006638A3 WO 2009006638 A3 WO2009006638 A3 WO 2009006638A3 US 2008069365 W US2008069365 W US 2008069365W WO 2009006638 A3 WO2009006638 A3 WO 2009006638A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptides
retrograde transport
facilitating retrograde
seq
peptides facilitating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/069365
Other languages
English (en)
Other versions
WO2009006638A2 (fr
Inventor
Elaine L Bearer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dart Neuroscience LLC
Original Assignee
Dart Neuroscience LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dart Neuroscience LLC filed Critical Dart Neuroscience LLC
Priority to CA 2692603 priority Critical patent/CA2692603A1/fr
Priority to AU2008272810A priority patent/AU2008272810A1/en
Priority to EP08772440A priority patent/EP2170929A2/fr
Publication of WO2009006638A2 publication Critical patent/WO2009006638A2/fr
Publication of WO2009006638A3 publication Critical patent/WO2009006638A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des peptides facilitant le transport rétrograde et des utilisations de ceux-ci. Elle concerne en particulier les peptides de KlP VIE NPQ YFG ITN (SEQ ID NO: 1) et de KRE LGE GAF GKV FLA (SEQ ID NO: 2).
PCT/US2008/069365 2007-07-05 2008-07-07 Peptides facilitant le transport rétrograde et utilisations de ceux-ci Ceased WO2009006638A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA 2692603 CA2692603A1 (fr) 2007-07-05 2008-07-07 Peptides facilitant le transport retrograde et utilisations de ceux-ci
AU2008272810A AU2008272810A1 (en) 2007-07-05 2008-07-07 Peptides facilitating retrograde transport and their uses
EP08772440A EP2170929A2 (fr) 2007-07-05 2008-07-07 Peptides facilitant le transport retrograde et utilisations de ceux-ci

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94813007P 2007-07-05 2007-07-05
US60/948,130 2007-07-05

Publications (2)

Publication Number Publication Date
WO2009006638A2 WO2009006638A2 (fr) 2009-01-08
WO2009006638A3 true WO2009006638A3 (fr) 2009-02-26

Family

ID=40226829

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/069365 Ceased WO2009006638A2 (fr) 2007-07-05 2008-07-07 Peptides facilitant le transport rétrograde et utilisations de ceux-ci

Country Status (4)

Country Link
EP (1) EP2170929A2 (fr)
AU (1) AU2008272810A1 (fr)
CA (1) CA2692603A1 (fr)
WO (1) WO2009006638A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9056892B2 (en) 2011-09-09 2015-06-16 University Of Washington Retrograde transport peptide and use of same for delivery to central nervous system

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060239988A1 (en) * 2003-06-09 2006-10-26 Michael Fainzilber Neuronal regeneration and compound administration methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060239988A1 (en) * 2003-06-09 2006-10-26 Michael Fainzilber Neuronal regeneration and compound administration methods

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JULLIEN, J. ET AL.: "Trafficking of TrkA-green Fluorescent Protein Chimerae during Nerve Growth Factor-induced Differentiation.", J. BIOL. CHEM., vol. 278, no. 10, 2003, pages 8706 - 8716, XP002441154 *
UBHATTACHARYYA A. ET AL.: "Trk Receptors Function As Rapid Retrograde Signal Carriers in the Adult Nnervous System", J. NEUROSCI., vol. 17, no. 18, 1997, pages 7007 - 7016, XP008129452 *
ZENG, J. ET AL.: "A synthetic peptidecontaining loop 4 of nerve growth factor for targeted gene delivery.", J. GEN. MED., vol. 6, 2004, pages 1247 - 1256, XP008129453 *

Also Published As

Publication number Publication date
CA2692603A1 (fr) 2009-01-08
WO2009006638A2 (fr) 2009-01-08
AU2008272810A1 (en) 2009-01-08
EP2170929A2 (fr) 2010-04-07

Similar Documents

Publication Publication Date Title
NZ600731A (en) Oxyntomodulin peptide analogue
WO2010060821A3 (fr) Produits nettoyants et détergents contenant des protéases de bacillus pumilus
PT1601776E (pt) Vectores de expressão que compreendem o promotor ie2 do mcmv
MX2012001436A (es) Panel con campo sensor opticamente transparente.
WO2006066258A3 (fr) Lipoconjugaison de peptides
WO2010059051A3 (fr) Diagnostic rapide de pathogènes basé sur fret
WO2008022156A3 (fr) Système de reconnaissance de motif
WO2002079408A3 (fr) Peptides bioactifs courts et leurs procedes d'utilisation
WO2007048857A8 (fr) Utilisation de peptides inhibiteurs du tgf-beta1 dans la preparation d'un agent modulateur de la reponse immunitaire
WO2007060117A3 (fr) Proteines effectrices chimeres se liant a la keratine
EP2428222A3 (fr) Combinaisons de peptide de vaccin contre l'allergie aux chats
MX2010001856A (es) Proteina.
WO2004081021A3 (fr) Mimetiques d'oligomeres
WO2008093058A3 (fr) Peptides et leur utilisation
WO2010035107A3 (fr) Peptides et compositions destinés à prévenir l'adhérence cellulaire et procédés d'utilisation de ceux-ci
WO2007107516A3 (fr) Selection de d-aminoacides pour le haricot de soja
NZ609216A (en) Anticancer fusion protein
EP2402364A3 (fr) Nonapeptide avec activité anti-tumeur
WO2003074546A3 (fr) Peptide de liaison a la streptavidine
WO2010051056A3 (fr) Polypeptides anti-fcεri et leurs utilisations
WO2008153429A3 (fr) Protéase provenant de staphylococcus aureus, en particulier spia ou spib, peptides qu'elle reconnaît et leur utilisation
WO2011123858A3 (fr) Peptides ccn3 à visée thérapeutique et leurs analogues
TW200722436A (en) A peptide-immunoglobulin-conjugate
WO2012061113A3 (fr) Peptides de ciblage du cancer et leurs utilisations dans le traitement et le diagnostic du cancer
NZ589365A (en) Peptidyl diacylglycerides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08772440

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010515284

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2692603

Country of ref document: CA

Ref document number: 42/KOLNP/2010

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: MX/A/2010/000221

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2008772440

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020107001430

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2008272810

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2008272810

Country of ref document: AU

Date of ref document: 20080707

Kind code of ref document: A

ENPW Started to enter national phase and was withdrawn or failed for other reasons

Ref document number: PI0814001

Country of ref document: BR

Free format text: PEDIDO RETIRADO, UMA VEZ QUE, SEGUNDO O ART. 216 INCISO 2O DA LPI, O DOCUMENTO DE PROCURACAO NAO FOI PROTOCOLADO EM SESSENTA DIAS CONTADOS DA PRATICA DO PRIMEIRO ATO DA PARTE NO PROCESSO, E NAO HOUVE MANIFESTACAO DO REQUERENTE FRENTE A PUBLICACAO DO ARQUIVAMENTO DA PETICAO (11.6.1) NA RPI 2298 DE 21/01/2015.